Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.37
-1.06 (-3.27%)
Nov 20, 2026, 4:00 PM EST - Market closed
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.72 billion as of November 20, 2026. It is the 6,865th most valuable company in the world and the 1,794th biggest in the United States. Its market cap has increased by 0.31% in one year.
Market Cap
1.72B
Enterprise Value
1.30B
1-Year Change
0.31%
Global Rank
Country Rank
#1,794 United States
Category
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.72B, an increase of 150.34%. That is a compound annual growth rate of 66.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.72B | -13.95% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 (IPO) | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 1.81B |
| Replimune Group | 1.81B |
| Zymeworks | 1.80B |
| Fortrea Holdings | 1.79B |
| Stoke Therapeutics | 1.75B |
| First Tracks Biotherapeutics | 1.75B |
| Korsana Biosciences | 1.71B |
| Ultragenyx Pharmaceutical | 1.67B |